[Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)]

Z Rheumatol. 2009 Sep;68(7):575-7. doi: 10.1007/s00393-009-0509-4.

[Article in German]

Author

I Kötter¹

Affiliation

¹ Abt. II, Bereich Rheumatologie, Medizinische Universitätsklinik , Otfried-Müller-Str. 10, 72076, Tübingen, Deutschland. [email protected]

PMID: 19652987
DOI: 10.1007/s00393-009-0509-4

No abstract available

MeSH terms

Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Antineutrophil Cytoplasmic / immunology*
Cyclophosphamide / administration & dosage*
Cyclophosphamide / adverse effects
Drug Administration Schedule
Drug Therapy, Combination
Female
Glomerular Filtration Rate
Glomerulonephritis / complications
Glomerulonephritis / physiopathology
Humans
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / adverse effects
Male
Middle Aged
Prednisolone / administration & dosage
Pulse Therapy, Drug
Randomized Controlled Trials as Topic
Remission Induction
Treatment Outcome
Vasculitis / complications
Vasculitis / drug therapy*
Vasculitis / immunology*
Young Adult

Substances

Antibodies, Antineutrophil Cytoplasmic
Immunosuppressive Agents
Cyclophosphamide
Prednisolone